drugset / Press release

Material Information - The China NMPA has Accepted the Marketing Authorization Application of Ropeginterferon alfa-2b for ET

2025-07-16 · PharmaEssentia · original pharmaessentia.com ↗

Download Material Information - The China NMPA has Accepted the Marketing Authorization Application of Ropeginterferon alfa-2b for ET Previous Next

The release as fetched from its publisher. pharmaessentia.com ↗